Curious about what motivates clinical trial participants beyond compensation? We asked our Participant Advisory Committee about the rewards and recognition they value most. Their answers might surprise you! From small branded giveaways to personal calls from principal investigators, participants shared insights on what makes them feel truly appreciated. Small touches can make a big difference. We're listening closely to enhance the participant experience.
Velocity Clinical Research, Inc.
生物技术研究
Durham，North Carolina 23,612 位关注者
Delivering high-quality clinical trial data and patient care with unprecedented efficiency.
关于我们
Velocity is the world’s leading organization of fully integrated clinical research sites. With 90 sites and more than 220 investigators, Velocity partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, diagnostics, and combination products that could improve human health and wellbeing. Velocity offers unified research site solutions to efficiently provide the right patients, investigators, and research staff for clinical trials across the U.S. and Europe. The company also operates a technology hub in India, where it is unlocking a new era in clinical research by developing innovative systems to leverage expansive site, patient, and historical performance data. To learn more about how Velocity delivers high-quality data, exemplary patient care, and unprecedented efficiency for clinical trials at any scale, visit VelocityClinical.com.
- 网站
-
https://velocityclinical.com
Velocity Clinical Research, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- Durham，North Carolina
- 类型
- 私人持股
- 创立
- 2018
- 领域
- Clinical trials、Patient Recruitment、Vaccine Research、Pharmaceutical Research、Clinical Research、Vaccines、Neurology、Pediatrics、NASH、Infectious Disease、Dermatology、Women's Health、Gastroenterology、Alllergy、Medical Devices、Research Sites、Principal Investigators和Drug Development
地点
Velocity Clinical Research, Inc.员工
动态
-
Today on Indigenous Peoples' Day, we honor the rich cultures, histories, and contributions of Indigenous communities. Inclusivity and equity are essential to advance healthcare for all — let's continue to support and uplift Indigenous voices in research and medicine. #IndigenousPeoplesDay #InclusiveResearch #EquityInHealthcare
-
-
In his latest article for ACRP - Association of Clinical Research Professionals, Paul Evans outlines how integrated site organizations can pave the way for AI adoption and generate tangible value for the industry. Read the ACRP article:?https://lnkd.in/d4cpGCAP For sites, investigators, and patients, Gen AI has the potential to streamline recruitment, reduce manual labor, and accelerate trial processes. By leveraging large datasets and advanced language models in our VISION technology platform, we're already beginning to reshape the way clinical trials are conducted at Velocity. #AI #ClinicalTrials #PatientRecruitment #GenAI
-
-
Wondering what participants think of apps and automation in their clinical trial journeys? We recently asked our Participant Advisory Committee what they wish an app could (or shouldn't) do to improve their experience. At Velocity, their voice is informing the development of our VISION Engage mobile app. Listen in for insights and expectations on how technology affects the participant's journey.
-
Earlier this year, Velocity hosted a powerful discussion with former U.S. Surgeon General Jerome Adams, MD, MPH, exploring the critical need to close trust gaps and enhance health equity in clinical trials. Dr. Adams highlighted that the pandemic underscored the importance of diversity in research, pointing to Operation Warp Speed as a pivotal moment where representation in trials was not just a moral imperative but essential for ensuring safety and efficacy across all populations. “We’re not starting at zero,” Dr. Adams reminded us, “we’re starting at less than zero” when it comes to earning the trust of historically marginalized communities. At Velocity, we are committed to increasing diversity in clinical trials by fostering meaningful connections with local communities, ensuring equitable healthcare access, and delivering more generalized trial results. Learn more about Dr. Adams' insights and how we’re working toward a more inclusive future in clinical research. #HealthEquity #DiversityInClinicalTrials #VelocityCARES #ClinicalResearch
-
In honor of #PAWeek, we would like to recognize the incredible work Physician Assistants do — from being on the frontline of health care every day, to playing a vital role in clinical research. Thank you to all PAs on the Velocity team! #PAsGoBeyond
-
-
Evelyne Mabouellet Newton, Vice President, Business Development, Europe will join a panel discussion at the second-annual IQVIA Connected Research Community Summit later this month at their Barcelona office. Later this October, Evelyne will share her expertise during the Driving Increased Diversity and Inclusion in Clinical Trials presentation.
-
-
#ObesityWeek, hosted by The Obesity Society is a month away in #SanAntonio! Sarah Smiley, DO, FACP, Diabetes and Obesity CARE Council Leader; Gregg Lucksinger M.D., Diabetes and Obesity CARE Council Leader; Nadege Gunn, MD, CPI, DABOM, MASH CARE Council Leader; Fritz Raiser, DO, Principal Investigator; and Christy Godwin, Sr. VP, Strategic Partnerships will be in attendance, so be sure to set up some time to connect with us.
-
-
As Nick Spittal states in a recent Advarra press release, membership in the Gene Therapy Ready (GTR) site network "allows Velocity to start studies over a month faster and provides a meaningful credential and important validation that increases sponsors' confidence in our specialized capabilities to conduct complex clinical research safely." All Velocity sites are fully prepared to support cell and gene therapy (CGT) clinical trials. With 220+ investigators, a global laboratory network, and sites with longstanding specialty research experience, Velocity can deliver patients for everything from large vaccine trials to focused cancer and rare disease trials involving genetically engineered therapies. Read the full press release: https://lnkd.in/g2kKM3Gs #ClinicalTrials #GeneTherapy
-
-
Today, around the world and at our six sites in Germany, we celebrate German Unity Day — a symbol of unity, freedom, and strength. At Velocity, we champion the power of collaboration and shared progress. Together, we can continue to break boundaries and drive innovation in healthcare. #TagDerDeutschenEinheit #UnityThroughResearch #InnovationInHealthcare
-